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Neutrophils (phagocytic granulocytes) are the most abundant circulatory white blood cells in the body. Within a 
few hours of tissue damage or infection, they 
can exit the blood vasculature and infiltrate 
the inflamed tissue to engulf and destroy 
bacteria and fungi1. Because neutrophil 
development and migration are tightly 
controlled in healthy individuals, abnormal 
values in absolute blood neutrophil 
count can indicate acquired or congenital 
neutrophil disorders. In addition, the 
functionality of human blood neutrophils 
can be tested through the characterization of 
cell-surface markers by flow cytometry and 
via in vitro measurements of phagocytosis, 
respiratory burst, microbial killing and cell 
adhesion2. Yet these assays do not provide 
any insight into how neutrophils coordinate 
their dynamics and effector processes, 
as occur in inflamed or infected tissues. 
Because of technical limitations in the 
identification of neutrophils at single-cell 
resolution and in the direct observation of 
their live dynamics in humans, information 
about how human-neutrophil populations 
coordinate the antimicrobial tissue response 
remains scarce. Writing in Nature Biomedical 
Engineering, Daniel Irimia and colleagues 
now describe an elegant in vitro solution 
for monitoring the swarming response of 
human neutrophils, enabling the detailed 
analysis of neutrophil-derived factors 
released during swarming3.
Animal models have helped to uncover 
the extravascular tissue dynamics of 
neutrophils in inflamed mammalian 
tissues. Over the past decade, intravital 
imaging of mouse strains with cell-specific 
fluorescent reporters has allowed the direct 
live observation of neutrophils in tissues of 
living anesthetized mice4 and the discovery 
of a special form of neutrophil-population 
dynamics, termed neutrophil swarming, 
where groups of individual neutrophils 
undergo phases of highly directed and 
coordinated movement before clustering 
(Fig. 1a). To date, neutrophil swarms have 
been seen in several mouse models of 
tissue wounding, of sterile inflammation 
and of infection with various pathogens 
(including bacteria, fungi and parasites4,5). 
The formation of these dense neutrophil 
clusters is host-protective, contributing to 
the isolation of healthy tissue from sites 
of wounding and infection. In contrast, 
excessive accumulation of neutrophils can 
interfere with the integrity and functionality 
of an organ. Therefore, neutrophil swarms 
are considered an essential process of 
the body’s innate immune response, and 
mediate a fine balance between tissue 
protection and destruction.
Detailed analyses of the molecular 
mechanisms behind neutrophil swarming 
are especially challenging in the complexity 
of mouse tissues, and impossible in humans. 
The systemic or local administration of 
blocking antagonists or chemical inhibitors 
globally interfere with protein function in 
all cells in the treated tissues and are often 
inconclusive regarding cell-specific effects. 
Moreover, the exact local concentration of 
blocking reagents at a certain tissue region 
can only poorly be controlled, which makes 
conclusions difficult when blocking effects 
are not observed. Furthermore, the exact 
tissue geometry and cellular composition 
is specific for a particular microscopic 
field of view, which limits comparisons of 
neutrophil behaviour between different 
tissue sites6. Hence, most intravital-imaging 
studies in mice have remained descriptive, 
categorizing swarms according to their 
morphology, dynamics and persistence. 
Systematic screening of candidate molecules 
for mediating neutrophil swarming has 
recently been carried out in mice and 
provided an initial map of signals controlling 
swarm formation7. However, no single signal 
could be identified that uniquely mediates 
swarming, suggesting that there exists a 
complex, multilayered network of pro- and 
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Figure 1 | Comparison of mouse-neutrophil swarming in situ and human-neutrophil swarming in vitro. 
a, Two-photon intravital microscopy of inflamed and infected mouse tissues has uncovered neutrophil 
swarming dynamics, such as the formation of a neutrophil cluster in over 1 hour in response to local tissue 
damage in the dermis of the mouse ear. b, Microscale arrays of clusters of zymosan particles (red) trigger 
the swarming behaviour of neutrophils isolated from human blood3. Micrographs (middle) represent an 
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anti-inflammatory signals that fine-tune the 
neutrophil swarming response.
By using soft-lithography techniques, 
Irimia and co-authors developed large 
microscale arrays of fluorescent particle 
clusters of zymosan (protein–carbohydrate 
complexes, prepared from the cell wall of 
the non-pathogenic yeast Saccharomyces 
cerevisae, that represent a classic 
experimental fungal stimulus for immune 
cells) amenable to study neutrophil swarms 
of any species, including human neutrophils. 
The clusters of zymosan particles were 
manufactured by first micropatterning 
a cationic copolymer polyelectrolyte of 
acrylamide before precisely trapping 
controlled numbers of the negatively 
charged zymosan particles. The zymosan 
particles can bind to specific cell-surface 
receptors on neutrophils to activate their 
oxidative burst, the secretion of pro-
inflammatory mediators and phagocytosis 
(uptake of the particle by the phagocyte). 
The authors found that both the size and 
the spacing of zymosan-particle clusters 
were critical for triggering neutrophil 
swarm formation. Smaller clusters of one 
or two zymosan particles were taken up by 
individual neutrophils and did not induce 
swarming. However, clusters of more than 
three zymosan particles and spacings larger 
than 20 μm between clusters were required 
for inducing neutrophil swarming.
Irimia and co-authors’ microarrays 
allow for the synchronized induction of 
thousands of neutrophil swarms. Thus, these 
microarrays in combination with live-cell 
imaging represent a high-throughput, 
standardized and precisely controlled 
experimental system to study neutrophil 
swarming (Fig. 1b). The authors confirmed 
existing data from mouse studies and 
provide new molecular insight into the 
swarming process of human neutrophils in 
response to zymosan particles. In particular, 
they show that human neutrophils 
undergo three distinct dynamic phases of 
swarming: scouting, swarm growth, and 
swarm stabilization (as had been observed 
for mouse neutrophils in models of small 
ear-skin injuries8). By micropatterning 
glass slides with zymosan particles of 
different size next to each other, the authors 
mimicked in vivo situations of transient 
neutrophil swarming, where cells move out 
of smaller swarm centres and are attracted 
to larger nearby clusters (the formation of 
multiple transient swarms is a common 
phenomenon of mouse tissues diffusely 
infected with bacteria or fungi2). The authors 
also show that multiple chemoattractants 
synergize to optimize the formation of 
human-neutrophil swarms. Moreover, they 
quantified molecules released by swarming 
neutrophils into the medium supernatant 
by lipid and protein profiling and identified 
unexpected candidate molecules for the 
modulation of swarming. A major advantage 
of the in vitro microarray approach is that 
the low volume of supernatant enables 
a sensitive readout for measuring low 
amounts of signalling molecules released 
by neutrophils at different stages during 
swarming. Notably, the authors used the 
approach for the analysis of clinical samples, 
identifying impaired swarming behaviour 
of neutrophils in patients suffering trauma, 
autoimmune disease and sepsis. They also 
show that neutrophils isolated from patients 
recovering from trauma regained their 
ability for optimal neutrophil swarming. 
Hence, the technology also holds promise 
for therapeutic screening and monitoring 
in the clinic.
Irimia and colleagues’ microarray 
technology builds on recent developments 
in the fields of microfabrication and 
microfluidics, and aims at mimicking 
aspects of immune-cell migration 
in physiological tissues9–11. Similar 
micropatterning technology could be used 
for the investigation of neutrophil swarming 
in response to other microbial stimuli and 
even living pathogens, to provide insight 
into how pathogens shape the secretome 
and swarming behaviour of neutrophils, and 
could also serve as a basis for new treatments 
to enhance the ability of neutrophils to 
contain areas of tissue infection. Moreover, 
the addition of other immune cell types 
(such as monocytes and macrophages) 
is likely to bring Irimia and co-authors’ 
technology even closer to the physiological 
situation, where tissue bystander cells may 
contribute to neutrophil swarming dynamics. 
Hence, the authors’ functional assay for 
the characterization of human neutrophils 
may hold predictive value for neutrophil 
migration in infected human tissues. ❐
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